EXECUTIVE ENGAGEMENTS
POOL
6572
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1052
Interactions with Platform & by Email
PARTICIPANTS
197
Unique # Participated
VALIDATIONS
89
Responses Validated*
COMPANIES
93
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
210
PAGES
333
EDITION
20
PRICE
USD 5450
CODE
MCP-6811
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Next Generation Sequencers estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$17 Billion by 2027, growing at a CAGR of 18.3% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 19.9% CAGR and reach US$11.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Platforms segment is readjusted to a revised 16.1% CAGR for the next 7-year period.
The Next Generation Sequencers market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2027 trailing a CAGR of 23.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13% and 16.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 13.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$612.4 Million in the year 2020 will reach a projected size of US$1.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.7 Billion by the year 2027, while Latin America will expand at a 16.4% CAGR through the analysis period.
SELECT PLAYERS
Agilent Technologies, Inc.; Becton, Dickinson and Company; Fluidigm Corporation; Illumina Inc.; Oxford Gene Technology; Oxford Nanopore Technologies; Pacific Biosciences of California Inc.; QIAGEN N.V.; RainDance Technologies Inc.; Roche Sequencing; Thermo Fischer Scientific Inc.
SEGMENTS
» Product Type (Consumables, Platforms, Services) » Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Next Generation Sequencing Techniques Transform the Genomics Space |
| Recent Market Activity |
| Next Generation Sequencers (NGS): A High-Throughput Sequencing Technology |
| US Leads the NGS Market, Asia-Pacific to Foster Future Growth |
| Academic & Research Dominates NGS Market |
| Oncology Testing - The Application with Most Promising Opportunities for NGS Technology |
| Declining Cost of Sequencing to Fuel Adoption of NGS Systems |
| After Dramatic Price Declines, Is NGS Market Positioned for Further Disruption? |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Agilent Technologies Inc. (US) |
| Becton, Dickinson and Company (BD) (US) |
| Fluidigm Corporation (US) |
| Genomatix GmbH (Germany) |
| Illumina, Inc. (US) |
| Oxford Gene Technology (UK) |
| Oxford Nanopore Technologies (UK) |
| Pacific Biosciences of California, Inc. (US) |
| QIAGEN N.V. (The Netherlands) |
| RainDance Technologies, Inc. (US) |
| Roche Sequencing (US) |
| Shenzhen BGI Diagnosis Co., Ltd. (China) |
| Thermo Fisher Scientific, Inc. (US) |
| 3. MARKET TRENDS & DRIVERS |
| Expanding Applications of NGS Technology |
| NGS Revolutionizes Drug Discovery and Development Space |
| Genetic Information offered by NGS Aids in Drug Development Process |
| Revolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of Precision Medicine |
| Rising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS Market |
| Comparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation Sequencing Methods for Identification of Driver Mutations |
| Key Cancer Statistics |
| NGS Emerges as a Game Changing Technology for Precision Oncology |
| Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to Patients |
| Growing Significance of NGS in Enabling Personalized Oncology - Timeline of Major Developments in Sequencing Technologies & Applications Related to Oncology |
| Personal Genomics Services - Blessing or Bane? |
| NGS Technology Drives RNA Sequencing in Transcriptomics |
| Longer Reach of a Read: A Key Feature Considered for Sequencing |
| qPCR - The Core Technique in NGS Technique |
| Development of New Systems & Platforms to Fuel NGS Utilization |
| Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption |
| Development Efforts Intensify in Long-Read Sequencing |
| Single-Cell Genomics: A Promising Application of NGS Technology |
| Shift from Tumor Biopsies to Cancer Liquid Biopsies |
| NGS Enhances Study of Antimicrobial Resistance |
| Effective Use of NGS Tools in Public Healthcare Systems |
| E-Infrastructure for Storage & Analysis of NGS Data |
| Explosive Growth in Sequencing Data Drives Focus onto Cloud Computing |
| NGS Hold an Edge Over CE Sequencing Method |
| Standardization of NGS Technique: A Critical Requirement for Wider Adoption |
| Challenges Confronting High-throughput Sequencing Market |
| High Machine Costs and Licensure Fees |
| Lack of Skilled Personnel |
| Absence of Regulatory Framework |
| Limited Access to Scientific Literature and Internet |
| Suboptimal Outsourcing Services |
| Regulations Related to NGS-Based Tests |
| Innovative Technologies |
| Nanopore Sequence Technology |
| Single-Molecule Real-Time technology (SMRT) |
| Direct Genomics’ Single Molecule Sequencing |
| TruSPADES Simplifies Metagenomics Sequencing |
| GnuBIO Platform |
| Electron Microscopy DNA Sequencing |
| FRET-based DNA Sequencing |
| Identification/Sequencing using Mechanical Properties |
| MALDI-TOF MS |
| RNAP Sequencing Method |
| Tunneling Currents DNA Sequencing |
| qPCR-Driven Library Quantitation Saves Time and Overheads |
| Achieving Trans-Block Uniformity |
| Enhancing qPCR Precision |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Next Generation Sequencers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biomarkers & Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biomarkers & Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biomarkers & Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Next Generation Sequencers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Next Generation Sequencers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Next Generation Sequencers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Next Generation Sequencers by Product Type - Consumables, Platforms and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Next Generation Sequencers by Product Type - Consumables, Platforms and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Next Generation Sequencers by Product Type - Percentage Breakdown of Value Sales for Consumables, Platforms and Services for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Next Generation Sequencers by Application - Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Next Generation Sequencers by Application - Percentage Breakdown of Value Sales for Diagnostics, Biomarkers & Cancer, Reproductive Health and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 93 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com